Stent Market Size & Share | Industry Forecast 2022

•

1 like•561 views

The world stents market would reach $16,666 million by 2022. A stent is a tube like implant that is implanted into the lumen of any blood vessel or a duct in order to keep the passage open. Varieties of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to allow the passage of food and beverages in patients suffering from esophageal cancer. Read here at: https://www.alliedmarketresearch.com/stents-market

Healthcare

STENTS MARKET
Global Opportunity Analysis
and Industry Forecast,
2014 - 2022
Pages: 122
Publish: 2016

• Defibrillation
STENTS MARKET
OVERVIEW
• In medicine, a stent is a metal or plastic tube inserted into the lumen of an
anatomic vessel or duct to keep the passageway open, and stenting is the
placement of a stent.
• A new report published by Allied Market Research, titled, "Stents Market -
Global Opportunity Analysis and Industry Forecast, 2014 - 2022", projects that
the global stents market would reach $16,666 million by 2022.
• coronary stents market is projected to be the fastest growing segment in terms of
both, value and volume, during 2016-2022.
Read more on:- https://www.alliedmarketresearch.com/stents-market
STENTS MARKET
OVERVIEW

• The bioabsorbable stents segment is projected to grow at a remarkable CAGR of
37.2%, owing to its growing adoption and technological advancements.
• The global synthetic grafts market is estimated to grow at a CAGR of 6.5% from
2016 to 2022.
• Asia-Pacific and Europe together accounted for over half of the share in the
stents market in 2015.
• The South Africa stents market is estimated to garner $132 million by 2022.
• China and Japan are the leading markets in the Asia-Pacific region and are
expected to continue their dominance throughout the forecast period.
STENTS MARKET KEY
FINDINGS

• An in-depth exposure to the world stents market is provided and light is shed on
market dynamics that would prove crucial in understanding the market
• Quantitative analysis of the current market and estimations through 2014-2022
would assist strategists to design business strategies to capitalize on the
prevailing opportunities in the market
• Porters Five Forces analysis examines the competitive structure of the world
stents market and also provides a deeper understanding of the influence factors
for market entry and market expansion
Get sample report at:- https://www.alliedmarketresearch.com/request-free-sample/1603
KEY BENEFITS OF
THE REPORT

STENTS
MARKET SEGMENTATION
STENTS MARKET
SEGMENTS
By Type By Material By Region

WORLD STENTS MARKET
SEGMENTATION, BY
PRODUCT

North America, Europe, Asia-Pacific, LAMEA
STENTS MARKET BY
REGION

The major drivers of the market include increasing geriatric population and high
incidence of heart failures & coronary disorders such as esophageal cancer, gall
bladder cancer, and other abnormalities. In addition, technological advancements in
stent systems, such as advent of bioabsorbable stents, have fueled the market
growth. Continuous improvements in healthcare insurance and reimbursement is
expected to boost the growth of the stents market in the developing and
underdeveloped countries, says lead analyst of the report, Deepa Tatkare. However,
high cost of these stents in the emerging countries is one of the major restraining
factors of the market, she further added.
Deepa Tatkare
STENTS MARKET

Follow Us On
Thank You!
For More Details
Visit us at
https://www.alliedmarketresearch.com/stents-market

This document provides a summary and table of contents for a market research report on the Indian coronary stent market forecast to 2019. The report contains 10 chapters analyzing topics such as the demographic and economic landscape in India, regulations for medical devices, taxation, the industry and production, import/export trends, consumers, pricing, the current market size and outlook. It aims to provide decision-makers in the coronary stent manufacturing industry with insights into market dynamics and growth opportunities in India.

Market Research Report : Coronary stents market in india 2014 - Sample

Netscribes, Inc.

For the complete report, get in touch with us at: info@netscribes.com Abstract: Netscribes latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types - those manufactured by MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies. Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents. Table of Contents:

Market Research Report :Coronary stents market in india 2013

Netscribes, Inc.

For the complete report, get in touch with us at : info@netscribes.com Abstract: Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the number of cath labs in the country and their subsequent expansion to smaller cities and towns, angioplasties will become more accessible to patients and will aid in further development of the market. Products available in the market can be divided into two types – those manufactured by MNCs that command high prices, and those manufactured by domestic companies that are generally priced lower. It is the MNCs that serve the majority of the market with almost all the big hospitals in tier I cities, where most of the angioplasties are performed, preferring to implant stents manufactured by foreign companies over those manufactured by their Indian counterparts. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy, whereas those manufactured by domestic companies fail to attain similar high standards of quality. Also, patients are generally unaware of the choices they have in terms of the types of stents and the various brands that are available in the market, and have to buy stents directly from the hospitals. Since profit margins are higher in case of foreign-manufactured stents, hospitals push for the sale of such stents rather than selling the Indian varieties. Table of Contents:

China medical device industry market demand and investment strategy report, 2...

Qianzhan Intelligence

This document provides an overview and analysis of the medical device industry in China. It discusses the industry's definition and importance to the national economy. It also analyzes the industry's policy environment, economic and social factors, technological development, supply and demand characteristics, imports and exports, competitive landscape, and investment trends. The document contains forecasts for the development prospects of various medical device segment industries and product markets in China from 2013 to 2017. It aims to help industry players better understand the market trends and make informed strategic decisions.

China medical monitor industry report, 2010

ResearchInChina

This document summarizes a report on the Chinese medical monitor industry from 2010 to early 2011. It provides an overview of the market size, key players, import and export trends of the Chinese medical monitor market. It also analyzes major companies in the industry such as Mindray, GE, Philips, Biolight, and Goldway. The report finds that the market grew over 20% annually from 2007 to 2009 and is expected to continue expanding due to China's growing healthcare needs and aging population. Domestic brands have an increasing presence though international brands still dominate the high-end sector of the market.

India bariatric surgical devices market size, share & forecast 2025

TechSci Research

China pharmaceutical excipients industry indepth research and investment stra...

Qianzhan Intelligence

The document discusses China's pharmaceutical excipients industry. It notes that the quality of excipients directly impacts the quality of drug preparations. The development of excipients in China has lagged the pharmaceutical industry. However, recent events have brought increased attention to excipients and driven their development. The report analyzes the industry's environment, market size, competitors, and prospects for development. It aims to provide a comprehensive overview of the current state and future trends in China's pharmaceutical excipients sector.

China venture capital industry indepth research and investment strategic plan...

Qianzhan Intelligence

This document provides a summary of the China Venture Capital Industry Indepth Research and Investment Strategic Planning Report from 2013 to 2017. It discusses the relevant background of the venture capital industry in China, including concepts, development opportunities and challenges, competition among venture capital entities, and venture capital models of different countries and regions. It also analyzes the operation and development of the venture capital industry in China, comparing Chinese venture capital institutions to those abroad. Finally, it examines typical successful and unsuccessful venture capital cases in China to identify factors contributing to their outcomes. The overall document conducts a comprehensive analysis of the current status and future trends of the venture capital industry in China.

The document provides an overview and analysis of China's industrial gas industry from 2011-2017. It discusses key topics like the industry definition, value chain, market environment, development status, economic indexes, supply and demand balance, imports and exports, and competitive structure. The analysis is based on extensive data collection and aims to help companies understand industry trends and make informed business decisions.

Active Pharmaceutical Ingredient (API) Market by Synthesis & Type

Radhika Patil

Pharmaceutical Offshoring Landscape A Syndicated Report

shekhar619

- The pharmaceutical industry is increasingly offshoring R&D activities to countries like India and China to take advantage of lower costs. India captured $125 million in offshored R&D spending in 2008 and China captured $375 million. - India has become a major destination for clinical trials and data management due to its large, skilled talent pool and lower costs that are 20-30% of developed markets. The market for outsourced clinical trials in India is growing at 31% annually. - Pharmaceutical companies are establishing facilities in India's Special Economic Zones which provide tax incentives and regulatory benefits to encourage further offshoring and foreign investment in the country.

Presentation on pharma companies

Edwin Jovit Ej

This document analyzes the pharmaceutical sector and the company Pfizer. It examines the market share and turnover of the top 10 pharmaceutical companies, finding that Johnson & Johnson has the highest turnover. It also analyzes the labor capital ratio of these companies, determining that Johnson & Johnson has the highest ratio, followed by Pfizer. Forecasting models are developed using Weka and SPSS to predict Pfizer's share price, finding a 94% accurate prediction of an increase in price in late 2014 and stabilization in late August. In conclusion, Pfizer is one of the top pharmaceutical companies globally and demonstrated strong performance.

Indian pharmaceutical industry

Vikram Gole

The Indian pharmaceutical industry is the third largest by volume and fourteenth largest by value. It supplies affordable drugs domestically while also exporting $10 billion in generic medicines annually. Key strengths include low production costs, a skilled workforce, and strong manufacturing capabilities. However, the industry also faces challenges like low R&D investment, regulatory issues, and international trade barriers that could hamper further growth.

China organosilicon industry market demand prospects and investment strategy ...

Qianzhan Intelligence

The document provides an overview and analysis of the organosilicon industry in China. It discusses the industry's development trends, market demand prospects, and investment strategies from 2013 to 2017. It analyzes factors such as the industry's structure, key players, market segments, supply and demand dynamics, import/export activities, competitive landscape, and development prospects. The report is intended to help organosilicon manufacturers, R&D institutions, marketing companies, and investors better understand the industry and identify opportunities.

Asia-Pacific Biotech News_Quintiles MDD bylined article_June 2016 issue

Simranjit Singh

1) Asia-Pacific represents a large potential market for medical devices due to its growing economies, populations, and unmet medical needs. However, the regulatory environment is complex, diverse, and rapidly changing across different countries in the region. 2) To succeed in this environment, companies must stay aware of regulatory changes and have the expertise to comply with different rules. For example, China and South Korea have introduced new approval pathways and requirements that companies must understand. 3) Outsourcing to partners with regulatory expertise and knowledge of different Asian markets can help companies overcome challenges, stay agile in response to changes, and maximize opportunities in the complex Asia-Pacific medical device market.

Medical Devices & Diagnostics Asia - Balancing Risk & Reward Whitepaper

Simranjit Singh

The Indian in vitro diagnostic market - an overview

Schenella Menda

Indian Pharmaceutical Industry

Aklanta Kalita

The document discusses India's pharmaceutical industry, including its current size and growth rate. It notes that formulations make up 79% of the industry while bulk drugs account for 21%. The background section outlines how India's Patents Act of 1970 only recognized process patents and led to increased domestic production. It also discusses how India transitioned to a product patent regime in 2005 to comply with TRIPS and how this has impacted multinational companies investing in India.

Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...

Aiswariya Chidambaram

Pharmaceuticals Sector Report October 2017

India Brand Equity Foundation

The document provides an overview of the pharmaceutical industry in India. Some key points: - The Indian pharmaceutical industry is expected to grow at a CAGR of 12.89% until 2020 to reach $55 billion in size. India accounts for 20% of global generic drug exports. - Major segments of the industry include active pharmaceutical ingredients, formulations, biosimilars, and contract research and manufacturing. Generics account for 70% of the domestic market. - Leading therapeutic segments are anti-infectives, cardiovascular, and gastro-intestinal drugs. The biotechnology industry in India is also growing rapidly and is projected to reach $100 billion by 2025. - Pharmaceutical exports from

Israel medical devices industry - Market Overview

Meidata

Comprehensive overview of the medical devices industry in Israel. Israel is well known for its innovative medical devices industry and despite the unfavorable global economic climate this sector has been steadily growing. As of August 2012, there are 656 medical devices companies in Israel which constitute around 60% of the entire life sciences industry. It should be noted, however, that medical devices companies are typically very small and in Israel over 50% of all companies are based on only 5 employees or less. Only 19 companies employ over 100 workers. Most of the companies, almost 70%, have not yet reached the commercial stage and are still at various stages of their product development. The Israeli medical devices sector consists of 9 sub-sectors, the biggest of which is therapeutics (225 companies) followed by the monitoring & diagnostics sub-sector (141 companies). The most dominant sub-sector in terms of successful companies and advanced stage companies is the imaging sub-sector. This sector includes one of Israel's well-known and successful medical devices company – Given Imaging. The telemedicine sub-sector, while young, holds a great promise as will be further explained in this research. After a sharp drop in exports following the economic downturn in 2008, exports of medical devices has been steadily growing during the last years. In 2011 Israel exported over $1.6 billion worth of medical devices mainly to the US, Japan, China and Europe. The medical devices sector has always held a high risk for investors. Lately, this risk has grown due to uncertainty as to the future economic climate, more stringent regulation (by the FDA) and price pressures. Due to the fact that the US is the largest market for medical devices, FDA marketing approval is vitally important for medical devices companies. The fact that these approvals have become more difficult to obtain, deters some investors from investing before a company overcomes the regulatory hurdle. Generally, these risks are making investors more cautious and less likely to invest in early stage companies. This means that many companies will not make it to the finish line, not necessarily because their products are not good enough but because they do not have enough funds to see it through.

Impacts of COVID-19 on Indian Stock Market

Muhammad Awais

Phamaceutical sector in india

Dipankar Biswas

Indian pharma industry 2014-15

Balaji Roy

The document summarizes the evolution of the Indian pharmaceutical industry over several phases from 1970 to the present. It began with foreign company domination and a lack of organized Indian companies. From 1970-1980 the government instituted controls over drug prices and local companies began to grow. From 1980-1990 the industry expanded domestically and internationally. From 1990-2000 research became a greater focus. Currently India has over 3000 pharmaceutical companies and aims to be a global leader in drug manufacturing due to lower costs. The industry has seen steady growth between 13-14% in recent years.

Market Research Report : Clinical trials market in india 2014 - Sample

Netscribes, Inc.

The clinical trials market in India was valued at INR x1 billion in 2013 and is estimated to reach INR x2 billion by 2018, growing at a CAGR of y1%. India's share of the global clinical trials market was y2% in 2013. Key drivers of growth include lower costs, a large patient population, and increasing R&D spending by pharmaceutical companies. However, new regulations have also brought challenges such as delays in approval and a shortage of research professionals. The document provides an overview of the market size and growth drivers, government regulations, and major players in the clinical trials industry in India.

Pharmaceutical market india a comprehensive industry analysis - Reports Corner

Reports Corner

"1.0 Summary “Pharmaceutical Market: India, A Competitive Industry Analysis” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This report scrutinises top Indian pharmacos and their battle within domestic and international therapeutic markets. The business environment in which they compete is analysed as are key drivers, constraints, challenges and opportunities. The Indian pharmaceutical market is set to become the eight largest pharma market globally by 2015. In 2012 it was worth $13 billion. It is forecast to reach $50 billion by 2015 and increase its dominance as a leading player in Asia. It is predicted that the Indian pharma market will be a significant global competitor by 2020 with an expected worth of up to $74 billion. This report describes the current therapeutics that are propelling the biopharmaceutical market in India. It examines the current economic climate and how India compares to other emerging markets and also evolved markets such as the US and Europe. Current developments relating to patent expirations, government funding, and regulations are discussed. The emerging trends that appear in key sub-markets such as generics, oncology, cardiovascular, diabetes and vaccines are elucidated and analysed. This study reveals market figures of the overall Indian pharmaceutical market and sub-markets. Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry. https://www.reportscorner.com/reports/15826/Pharmaceutical-Market:-India-A-Comprehensive-Industry-Analysis/

Market Research Report: Medical Devices Market in India 2010

Netscribes, Inc.

For the complete report, get in touch with us at: info@netscribes.com The medical device market is a thriving segment of the healthcare industry in India. Rise in the number of hospitals and increasing requirement of healthcare facilities is creating a need for sophisticated devices and equipments which can provide accurate treatment to individuals. The global market is growing rapidly and India has also joined the bandwagon of being one of the fastest growing countries in this respect. The government is expected to develop a regulatory structure leading to quality products by manufacturers. However, the regulatory structure currently lacks active participation from the government but with the increase in competition in the sector, it is due to follow in a very short period of time. Currently, imports account for a large share of primarily the high-end medical device segment and players are gearing up establishing large manufacturing facilities in India to tap the opportunities. The report begins with an introduction of medical devices in India and their classification based on relative parameters set by the Indian Government. The market overview section provides the market size and growth. It also provides an overview of the segments that are existent in the market along with their market share. The import and the export structure of the medical devices in India are also given. This is followed by an analysis of the drivers fueling growth in the market including increasing hospital infrastructure, increasing healthcare spending, changing demographics and growing target consumer group, increasing lifestyle diseases and therapies and increasing medical tourism in India. The key challenges identified include high dependency on exports and lack of standard regulatory structure. The key trends in the market have also been identified including outsourcing/relocating of manufacturing facilities, increasing joint ventures and tie-ups and various exhibitions and trade fairs. The involvement of government in this industry is also included. It shows the role of various government bodies that are involved in regulating this sector and also involved in the promotion of this sector in India. It also highlights the regulations set in terms of assessment of a medical device manufacturing organization in India along with the procedure involved in registration of an organization and procurement of an import license. The initiatives taken by the government in order to promote the sector by providing tax reliefs and import duty relaxations have also been highlighted. The competitive landscape provides a look into the nature of the market, and the active players in the market. A product portfolio matrix is also given to highlight the dominant player in each segments of the market. Profiles of the major domestic and foreign players have been included. Furthermore, key developments in the market over the last one year have also been highlighted.

Indian Clinical Research Industry

tanmayshinde

This document summarizes statistics on the clinical research industry. It finds that India has experienced strong growth in clinical trials in recent years and is emerging as a top destination for outsourced clinical research. While the Indian clinical research market is growing rapidly, it remains relatively small compared to the global market and there is a need for more trained professionals to support further industry expansion.

Angioline calypso presentation (final version)

Mikhail Moris

This document summarizes postmarketing studies comparing the Russian-made Calypso drug-eluting stent to analogous foreign stents. It describes two ongoing comparative registry studies - E-Calypso and Patriot - that are evaluating the safety and efficacy of the Calypso stent versus competitors like the Resolute Integrity and Xience Prime stents. The document outlines the study designs, endpoints, inclusion/exclusion criteria and administrative details of the comparative studies which are taking place in Russia through 2016. It also provides technical specifications and performance data indicating the Calypso stent is competitive with leading foreign stents while offering significant cost savings.

Coronary Stent - Part A - Overview

Amir Kraitzer

Stent design aspects and coronary artery disease were discussed. Coronary artery disease is a leading cause of death worldwide. Historical developments in treatments including balloon angioplasty, bare metal stents, and drug-eluting stents were covered. Mechanisms of in-stent restenosis and approaches to prevent it such as mechanical techniques, drug coatings, and biodegradable stents were described. Clinical measures for evaluating restenosis outcomes were defined.

What's hot

China industrial gas industry market forecast and investment strategic planni...

Qianzhan Intelligence

Active Pharmaceutical Ingredient (API) Market by Synthesis & Type

Radhika Patil

Pharmaceutical Offshoring Landscape A Syndicated Report

shekhar619

Presentation on pharma companies

Edwin Jovit Ej

Indian pharmaceutical industry

Vikram Gole

China organosilicon industry market demand prospects and investment strategy ...

Qianzhan Intelligence

Asia-Pacific Biotech News_Quintiles MDD bylined article_June 2016 issue

Simranjit Singh

Medical Devices & Diagnostics Asia - Balancing Risk & Reward Whitepaper

Simranjit Singh

The Indian in vitro diagnostic market - an overview

Schenella Menda

Indian Pharmaceutical Industry

Aklanta Kalita

Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...

Aiswariya Chidambaram

Pharmaceuticals Sector Report October 2017

India Brand Equity Foundation

Israel medical devices industry - Market Overview

Meidata

Impacts of COVID-19 on Indian Stock Market

Muhammad Awais

Phamaceutical sector in india

Dipankar Biswas

Indian pharma industry 2014-15

Balaji Roy

Market Research Report : Clinical trials market in india 2014 - Sample

Netscribes, Inc.

Pharmaceutical market india a comprehensive industry analysis - Reports Corner

Reports Corner

Market Research Report: Medical Devices Market in India 2010

Netscribes, Inc.

Indian Clinical Research Industry

tanmayshinde

What's hot (20)

China industrial gas industry market forecast and investment strategic planni...

Active Pharmaceutical Ingredient (API) Market by Synthesis & Type

Pharmaceutical Offshoring Landscape A Syndicated Report

Presentation on pharma companies

Indian pharmaceutical industry

China organosilicon industry market demand prospects and investment strategy ...

Asia-Pacific Biotech News_Quintiles MDD bylined article_June 2016 issue

Medical Devices & Diagnostics Asia - Balancing Risk & Reward Whitepaper

The Indian in vitro diagnostic market - an overview

Indian Pharmaceutical Industry

Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...

Pharmaceuticals Sector Report October 2017

Israel medical devices industry - Market Overview

Impacts of COVID-19 on Indian Stock Market

Phamaceutical sector in india

Indian pharma industry 2014-15

Market Research Report : Clinical trials market in india 2014 - Sample

Pharmaceutical market india a comprehensive industry analysis - Reports Corner

Market Research Report: Medical Devices Market in India 2010

Indian Clinical Research Industry

Viewers also liked

Angioline calypso presentation (final version)

Mikhail Moris

Coronary Stent - Part A - Overview

Amir Kraitzer

MT5007: The coronary stent revolution (A group project for the Management of ...

Stefan

This project tracks the development of coronary artery disease interventions, ranging from early method of cardiac bypass to balloon angioplasty to the development of biomedical stents. Analyses of the competitive climate in the biomedical stents industry is discussed. New market and technology strategies are proposed for a regional MNC to leverage domestic industry infrastructure within emerging economies accompanied by a projected 30% growth in CAD due to increased consumption trends and lifestyle factors, e.g. smoking.

Coronary stent

Other Mother

This document summarizes coronary stents, including their purpose, types, history, procedure for placement, and future advancements. Stents are small mesh devices that are placed in arteries to keep them open and improve blood flow after balloon angioplasty. There are bare metal stents and drug-eluting stents, which combat re-narrowing after placement. The first coronary stent was placed in 1986, and drug-eluting stents were introduced in 2001 to further reduce re-narrowing. Placement involves threading a catheter through an artery to the blockage and expanding a balloon and stent to open the artery. Future advancements include bioresorbable polymers that dissolve after artery healing is complete.

Bioabsorbable Scaffolds

Ankur Batra

This document summarizes the current status of bioresorbable scaffolds for treating coronary artery disease. It describes the materials used in bioresorbable scaffolds like PLLA and magnesium, as well as some of the first bioresorbable scaffolds developed. Potential benefits of bioresorbable scaffolds include reduced risk of thrombosis, less inflammation, and restoration of vasomotion. However, limitations remain such as lack of large randomized trials and limited scaffold sizes currently available. While bioresorbable scaffolds show advantages over permanent stents, more evidence is still needed before widespread adoption.

Bioabsorbable Drug-Eluting Cardiac Stent Analysis

University of Toronto

The document discusses Abbott's bioabsorbable everolimus-eluting stent and its potential advantages over drug-eluting stents. It proposes a clinical trial to test the bioabsorbable stent in diabetic patients to demonstrate improved safety and efficacy compared to drug-eluting stents in a high risk population. Quantitative analyses estimate the cost-effectiveness and return on investment of the bioabsorbable stent if thrombosis and revascularization rates are reduced compared to drug-eluting stents.

Different Coronary stent design PPT

LPS Institute of Cardiology Kanpur UP India

This document discusses different designs of coronary stents. It begins by providing background on the development of coronary stents and their approval for use. It then describes some of the earliest stent designs, including the Gianturco-Roubin coil stent and the Palmaz-Schatz slotted tube stent. The document goes on to discuss various aspects of stent design that can impact performance, such as the geometric configuration, materials used, coatings, and drug-eluting capabilities. Key design considerations like strut thickness, number of struts, and mechanical properties are also reviewed.

The story of coronary stent

Ramachandra Barik

Viewers also liked (8)

Angioline calypso presentation (final version)

Coronary Stent - Part A - Overview

MT5007: The coronary stent revolution (A group project for the Management of ...

Coronary stent

Bioabsorbable Scaffolds

Bioabsorbable Drug-Eluting Cardiac Stent Analysis

Different Coronary stent design PPT

The story of coronary stent

More from Allied Market Research

Wireless charging market Future Analysis 2025

Stent Market Size & Share | Industry Forecast 2022

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (8)

More from Allied Market Research

More from Allied Market Research (20)

Recently uploaded

Recently uploaded (20)

Stent Market Size & Share | Industry Forecast 2022